Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Isabella Elias Yonezawa Ogusuku"'
Autor:
Karin Teppert, Isabella Elias Yonezawa Ogusuku, Caroline Brandes, Vera Herbel, Nora Winter, Niels Werchau, Svetlana Khorkova, Christian Wöhle, Nojan Jelveh, Kevin Bisdorf, Boris Engels, Thomas Schaser, Kathleen Anders, Annette Künkele, Dominik Lock
Publikováno v:
Molecular Therapy: Oncology, Vol 32, Iss 2, Pp 200797- (2024)
Acute myeloid leukemia (AML), a fast-progressing hematological malignancy affecting myeloid cells, is typically treated with chemotherapy or hematopoietic stem cell transplantation. However, approximately half of the patients face relapses and 5-year
Externí odkaz:
https://doaj.org/article/b2b5998bca9443e8b534fb7655519697
Autor:
Isabella Elias Yonezawa Ogusuku, Vera Herbel, Simon Lennartz, Caroline Brandes, Eva Argiro, Caroline Fabian, Carola Hauck, Conny Hoogstraten, Sabrina Veld, Lois Hageman, Karin Teppert, Georgia Koutsoumpli, Marieke Griffioen, Nadine Mockel-Tenbrinck, Thomas Schaser, Rosa de Groot, Ian C.D. Johnston, Dominik Lock
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 2, Pp 101224- (2024)
Acute myeloid leukemia (AML) is a heterogeneous malignancy that requires further therapeutic improvement, especially for the elderly and for subgroups with poor prognosis. A recently discovered T cell receptor (TCR) targeting mutant nucleophosmin 1 (
Externí odkaz:
https://doaj.org/article/722f01dd698746e597d61bf1c55d549c